Cord Blood Stem Cell TransplantationFetal BloodHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationMonocrotophosTransplantation, AutologousTransplantation, HomologousStem Cell TransplantationPenile ImplantationStem CellsTransplantation ConditioningHematopoietic Stem CellsBlood BanksGraft vs Host DiseaseLymphomaHematologic NeoplasmsHematopoietic Stem Cell MobilizationAntigens, CD34Lymphoma, Non-HodgkinBone Marrow TransplantationMelphalanGranulocyte Colony-Stimulating FactorGraft SurvivalLeukapheresisCombined Modality TherapyTreatment OutcomeTransplantation ChimeraCell DifferentiationBusulfanCyclophosphamideMyeloablative AgonistsMultiple MyelomaTissue DonorsRecurrenceAntineoplastic Combined Chemotherapy ProtocolsBlood Component RemovalRemission InductionLymphoma, B-CellLymphoma, T-CellMice, SCIDHistocompatibility TestingLiver TransplantationWhole-Body IrradiationHistocompatibilityCells, CulturedLeukemiaRetrospective StudiesDisease-Free SurvivalAntineoplastic Agents, AlkylatingImmunosuppressive AgentsVidarabineHodgkin DiseaseEtoposideMesenchymal Stem Cell TransplantationSurvival RateGraft vs Leukemia EffectSurvival AnalysisHematopoiesisLymphoma, Large B-Cell, DiffuseInfectionSalvage TherapyThiotepaLymphoma, FollicularTime FactorsTransplantation, IsogeneicVincristineCell TransplantationHematologic DiseasesLeukemia, Myeloid, AcuteKidney TransplantationEmbryonic Stem CellsPOEMS SyndromeAmyloidosisBlood CellsCytarabineSpinal CordMyelodysplastic SyndromesAdult Stem CellsFollow-Up StudiesFatal OutcomeHLA AntigensAnemia, AplasticCytomegalovirus InfectionsCarmustineMice, Inbred NODPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveImmunophenotypingIfosfamideLymphocyte DepletionTransplantation ImmunologyPlatelet CountPrognosisBurkitt LymphomaImmunosuppressionPrednisoneDoxorubicinNeoplasmsCyclosporinePluripotent Stem Cells